Tomorrow Investor

JFB Announces XTEND Wins Israeli Ministry of Defense Contract to Deploy Operational Drone Systems

JFB Secures $1.67M Israeli MoD Drone Systems Contract | GlobeNewsWire

$1.67M Contract Expands XTEND’s Footprint with Israeli Ministry of Defense, Reflecting Growing Demand for Deployable Autonomous Systems in Operational Environments TAMPA, Fla., April 21, 2026 (GLOBE NEWSWIRE) — JFB Construction Holdings (Nasdaq: JFB) announces that XTEND, a leader in software systems and artificial intelligence-powered robotics, has secured a contract with the Israeli Ministry of Defense (IMOD) to supply drone systems and services, with a total contract value of approximately $1.67 million (NIS 5 million).

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

JFB Construction Holdings (Nasdaq: JFB) has announced an important new partnership, securing a $1.67 million contract with the Israeli Ministry of Defense (IMOD) for operational drone systems. This deal signifies a robust expansion of XTEND‘s engagement within defense applications, reflecting the surging demand for autonomous systems.

  • $1.67M contract for drone systems and services.
  • Partnership with Israeli Ministry of Defense (IMOD).
  • Highlights growing demand for deployable autonomous systems.
  • Positions JFB for further collaborations within defense sectors.
  • Expected to enhance operational efficiency in military operations.

Why it matters: This contract cements JFB’s reputation as an innovator in defense technology, positioning the company for future growth.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.